Gabapentin Doesn't Increase Fall Risk, Study Suggests
By Dennis Thompson HealthDay Reporter
THURSDAY, Jan. 9, 2025 -- A pain-relieving medication might be safer for seniors than first thought.
A new study published Jan. 7 in the Annals of Internal Medicine says Gabapentin is widely used to help treat chronic pain and nerve pain, particularly as an alternative to opioid painkillers.
However, some have argued that gabapentin shouldn’t be prescribed to seniors, as it might increase their risk of damaging falls.
Those concerns are baseless, according to the study.
The study’s results show that gabapentin “was associated with fewer fall-related health care visits and … was not associated with an increase in more severe fall-related events,” concluded a research team led by Dr. Alexander Chaitoff, an assistant professor of internal medicine with the University of Michigan.
“These considerations should be incorporated into conversations with patients who are considering starting gabapentin treatment,” the team added.
Nearly 50 million prescriptions for gabapentin were written in 2020, but by 2022 those scripts had fallen by 20% after several studies found that the drug might increase fall risk for seniors.
Chaitoff and his colleagues suspected that this risk might be overblown, given that the painful conditions for which gabapentin is prescribed also increases risk of falls.
“Neuropathy, the most common indication for which gabapentin is prescribed, is also a known contributor to adverse health events, especially falls,” the researchers noted.
The researchers decided to compare the safety of gabapentin against that of duloxetine, another drug prescribed for nerve pain that doesn’t have the same reputation for increasing fall risk.
The team gathered data for more than 57,000 seniors 65 or older prescribed either gabapentin or duloxetine between Jan. 2014 and Dec. 2021 for nerve pain related to diabetes, shingles or fibromyalgia.
The results showed that gabapentin users actually had a 48% lower overall risk of any falls, compared to those taking duloxetine.
However, there was no difference between the two drugs when it came to the risk of experiencing a severe fall.
“Although we cannot claim that gabapentin does not lead to higher risk for falls at any time, our study does suggest that the risks of gabapentin as they relate to fall risk in the first 6 months of initiation are not greater, or potentially favorable, versus an alternative medication that might be prescribed instead,” the research team concluded.
Sources
- American College of Physicians, news release, Dec. 31, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Ladder Recall Follows Reports of Falls, Head Injuries and Broken Bones
FRIDAY, Aug. 15, 2025 — More than 122,000 ladders sold at Home Depot are being recalled because their locking mechanism can fail, putting users at risk of a fall. The...
Fighters From Poor Neighborhoods Might Have Higher Brain Risk
THURSDAY, Aug. 14, 2025 — It’s a time-honored and somewhat romantic tale: The young fighter who rises from poverty to make a name for themselves. But reality might...
Tamiflu Safe For Children, Study Concludes
THURSDAY, Aug. 7, 2025 — Researchers have debunked long-standing concerns that Tamiflu can cause neurological and psychiatric problems when given to influenza-stricken...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.